Description
Indication & Scope
SiShuJing® Anrikefon Injection provides relief of mild to moderate pain after abdominal surgery in adult patients.
- Mechanism: Highly selective kappa-opioid receptor agonist that activates central and peripheral kappa opioid receptors to produce analgesic effects, with significantly lower risks of respiratory depression and addiction compared to traditional mu-opioid analgesics.
- Drug class: Selective kappa-opioid receptor agonist, injectable prescription analgesic medicine.
- Clinical use: Postoperative intravenous pain management for abdominal surgical procedures.
| Generic Name | Anrikefon Injection |
| Brand Name | SiShuJing |
| Ingredient | Anrikefon Injection |
| Dosage Form | Injection |
| Package | 1ml:0.1mg*4 vials/box |
| Conditions Treated | Mild and moderate acute postoperative pain following abdominal surgery |
| Taboos | Severe hypersensitivity to anrikefon or opioid excipients; patients with severe respiratory failure, untreated biliary colic or acute pancreatitis |
| Place of origin | China |
| Prescription type | Prescription-only |
| Storage Conditions | Store at 15°C to 30°C, sealed and protected from light |
| Manufacturer | HaiSiKe Pharmaceutical Co., Ltd. |
| Registration Authority | National Medical Products Administration (NMPA), China |
| Approval number | H20250014 |
| Approval Date | May 13, 2025 |
| Shelf Life | 24 months |
How to use ?
Recommended Dose: Weight-adjusted loading dose followed by patient-controlled bolus dosing for postoperative analgesia regimens.
Time: Initiate administration immediately after surgical wound closure in the operating room.
Instructions for use: Administered only via intravenous route, can be configured into patient-controlled analgesia pumps; dose adjustment based on patient pain response and vital signs.
Interaction: Concomitant use with other central nervous system depressants increases sedation and respiratory suppression risk.
Side effects: Dizziness, sedation, dry mouth, mild nausea, urinary retention, and rare bradycardia.
Important Notice
This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What is the main use of Anrikefon Injection?
It relieves mild to moderate acute pain after adult abdominal surgery.
What advantages does Anrikefon Injection have over traditional opioid analgesics?
It has much lower risks of respiratory depression and drug addiction.
What patients cannot use Anrikefon Injection?
Patients with severe respiratory failure and hypersensitivity are contraindicated.
What common side effects may appear after using Anrikefon Injection?
Dizziness, sedation, dry mouth and mild nausea are common clinical reactions.
SiShuJing® | Anrikefon Injection | Pain Relief of Surgery | DengYueRX
INN: Anrikefon Injection
Indications: Pain Relief of Surgery
Dosage Form: Injection
Strength: 1ml:0.1mg/vial
